ASX:ALAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

AROVELLA THERAPEUTICS ORD

$0.080

+$0.001 (+1.27%)

Day Range

$0.079 - $0.080

52 Week Range

$0.068 - $0.125

Volume

34.37K

Avg Volume (10D)

873.43K

Market Cap

$96.57M

Price Chart

Market Statistics

Open$0.079

Previous Close$0.079

Day High$0.080

Day Low$0.079

52 Week High$0.125

52 Week Low$0.068

Valuation

Market Cap96.57M

Shares Outstanding1.21B

Price to Book5.21

Trading Activity

Volume34.37K

Value Traded2.72K

Bid$0.078 × 128,227

Ask$0.080 × 6,442

Performance

1 Day-1.20%

5 Day-8.89%

13 Week-3.53%

52 Week-34.40%

YTD-11.83%

Technical Indicators

RSI (14)38.22

50-Day SMA$0.088

200-Day SMA$0.089

Arovella Therapeutics confirms anti-tumour effect of lead drug ALA-101 in treating certain cancers

Arovella Therapeutics (ASX: ALA) has presented new data at the American Association for Cancer Research annual meeting relating to lead drug ALA-101 as a novel ‘off-the-shelf’ therapy to treat CD19-expressing leukemias and lymphomas. The data presented used iNKT (invariant natural killer) cells expressing a chimeric antigen receptor (CAR) which targets the CD19 biomarker. The cells […]

1 min read

Imelda Cotton